BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 15390180)

  • 21. Germline ATM mutational analysis in BRCA1/BRCA2 negative hereditary breast cancer families by MALDI-TOF mass spectrometry.
    Graña B; Fachal L; Darder E; Balmaña J; Ramón Y Cajal T; Blanco I; Torres A; Lázaro C; Diez O; Alonso C; Santamariña M; Velasco A; Teulé A; Lasa A; Blanco A; Izquierdo A; Borràs J; Gutiérrez-Enríquez S; Vega A; Brunet J
    Breast Cancer Res Treat; 2011 Jul; 128(2):573-9. PubMed ID: 21445571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ataxia-telangiectasia genes and breast cancer risk in a French family study.
    Andrieu N; Cavaciuti E; Laugé A; Ossian K; Janin N; Hall J; Stoppa-Lyonnet D
    J Dairy Res; 2005; 72 Spec No():73-80. PubMed ID: 16180724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional consequences of ATM sequence variants for chromosomal radiosensitivity.
    Gutiérrez-Enríquez S; Fernet M; Dörk T; Bremer M; Lauge A; Stoppa-Lyonnet D; Moullan N; Angèle S; Hall J
    Genes Chromosomes Cancer; 2004 Jun; 40(2):109-19. PubMed ID: 15101044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Morbidity and mortality from ataxia-telangiectasia are associated with ATM genotype.
    Micol R; Ben Slama L; Suarez F; Le Mignot L; Beauté J; Mahlaoui N; Dubois d'Enghien C; Laugé A; Hall J; Couturier J; Vallée L; Delobel B; Rivier F; Nguyen K; Billette de Villemeur T; Stephan JL; Bordigoni P; Bertrand Y; Aladjidi N; Pedespan JM; Thomas C; Pellier I; Koenig M; Hermine O; Picard C; Moshous D; Neven B; Lanternier F; Blanche S; Tardieu M; Debré M; Fischer A; Stoppa-Lyonnet D;
    J Allergy Clin Immunol; 2011 Aug; 128(2):382-9.e1. PubMed ID: 21665257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Ataxia-telangiectasia and cancer: an open question].
    Rodriguez C; Theillet C
    Bull Cancer; 1997 Jul; 84(7):763-6. PubMed ID: 9339205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mice heterozygous for mutation in Atm, the gene involved in ataxia-telangiectasia, have heightened susceptibility to cancer.
    Spring K; Ahangari F; Scott SP; Waring P; Purdie DM; Chen PC; Hourigan K; Ramsay J; McKinnon PJ; Swift M; Lavin MF
    Nat Genet; 2002 Sep; 32(1):185-90. PubMed ID: 12195425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
    Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
    BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phenotypic cellular characterization of an ataxia telangiectasia patient carrying a causal homozygous missense mutation.
    Angèle S; Laugé A; Fernet M; Moullan N; Beauvais P; Couturier J; Stoppa-Lyonnet D; Hall J
    Hum Mutat; 2003 Feb; 21(2):169-70. PubMed ID: 12552566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer risks and mortality in heterozygous ATM mutation carriers.
    Thompson D; Duedal S; Kirner J; McGuffog L; Last J; Reiman A; Byrd P; Taylor M; Easton DF
    J Natl Cancer Inst; 2005 Jun; 97(11):813-22. PubMed ID: 15928302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer risk in heterozygotes for ataxia-telangiectasia.
    Geoffroy-Perez B; Janin N; Ossian K; Laugé A; Croquette MF; Griscelli C; Debré M; Bressac-de-Paillerets B; Aurias A; Stoppa-Lyonnet D; Andrieu N
    Int J Cancer; 2001 Jul; 93(2):288-93. PubMed ID: 11410879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two ATM variants and breast cancer risk.
    Thompson D; Antoniou AC; Jenkins M; Marsh A; Chen X; Wayne T; Tesoriero A; Milne R; Spurdle A; Thorstenson Y; Southey M; Giles GG; Khanna KK; Sambrook J; Oefner P; Goldgar D; Hopper JL; Easton D; Chenevix-Trench G;
    Hum Mutat; 2005 Jun; 25(6):594-5. PubMed ID: 15880680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of the breast cancer associated ATM 7271T>G (V2424G) mutation by gene expression profiling.
    Waddell N; Jonnalagadda J; Marsh A; Grist S; Jenkins M; Hobson K; Taylor M; Lindeman GJ; Tavtigian SV; Suthers G; Goldgar D; Oefner PJ; ; Taylor D; Grimmond S; Khanna KK; Chenevix-Trench G
    Genes Chromosomes Cancer; 2006 Dec; 45(12):1169-81. PubMed ID: 17001622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ATM heterozygosity and cancer risk.
    Concannon P
    Nat Genet; 2002 Sep; 32(1):89-90. PubMed ID: 12205473
    [No Abstract]   [Full Text] [Related]  

  • 34. The role of ataxia-telangiectasia heterozygotes in familial breast cancer.
    Chen J; Birkholtz GG; Lindblom P; Rubio C; Lindblom A
    Cancer Res; 1998 Apr; 58(7):1376-9. PubMed ID: 9537233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ATM gene founder haplotypes and associated mutations in Polish families with ataxia-telangiectasia.
    Mitui M; Bernatowska E; Pietrucha B; Piotrowska-Jastrzebska J; Eng L; Nahas S; Teraoka S; Sholty G; Purayidom A; Concannon P; Gatti RA
    Ann Hum Genet; 2005 Nov; 69(Pt 6):657-64. PubMed ID: 16266405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ataxia-telangiectasia and T-cell leukemias: no evidence for somatic ATM mutation in sporadic T-ALL or for hypermethylation of the ATM-NPAT/E14 bidirectional promoter in T-PLL.
    Luo L; Lu FM; Hart S; Foroni L; Rabbani H; Hammarström L; Yuille MR; Catovsky D; Webster AD; Vorechovský I
    Cancer Res; 1998 Jun; 58(11):2293-7. PubMed ID: 9622061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histopathological features of breast cancer in carriers of ATM gene variants.
    Balleine RL; Murali R; Bilous AM; Farshid G; Waring P; Provan P; Byth K; Thorne H; ; Kirk JA
    Histopathology; 2006 Nov; 49(5):523-32. PubMed ID: 17064299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Presence of ATM protein and residual kinase activity correlates with the phenotype in ataxia-telangiectasia: a genotype-phenotype study.
    Verhagen MM; Last JI; Hogervorst FB; Smeets DF; Roeleveld N; Verheijen F; Catsman-Berrevoets CE; Wulffraat NM; Cobben JM; Hiel J; Brunt ER; Peeters EA; Gómez Garcia EB; van der Knaap MS; Lincke CR; Laan LA; Tijssen MA; van Rijn MA; Majoor-Krakauer D; Visser M; van 't Veer LJ; Kleijer WJ; van de Warrenburg BP; Warris A; de Groot IJ; de Groot R; Broeks A; Preijers F; Kremer BH; Weemaes CM; Taylor MA; van Deuren M; Willemsen MA
    Hum Mutat; 2012 Mar; 33(3):561-71. PubMed ID: 22213089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The ATM gene and ataxia telangiectasia.
    Mavrou A; Tsangaris GT; Roma E; Kolialexi A
    Anticancer Res; 2008; 28(1B):401-5. PubMed ID: 18383876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ATM and breast cancer susceptibility.
    Ahmed M; Rahman N
    Oncogene; 2006 Sep; 25(43):5906-11. PubMed ID: 16998505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.